Applied Molecular Transport Inc. (AMTI) NASDAQ

$3.23 -0.38 (-10.53%)

Market Cap: $139.54M

As of 06/28/22 04:00 PM EDT. Market closed.

(AMTI)

Applied Molecular Transport Inc. (AMTI) NASDAQ

$3.23 -0.38 (-10.53%)

Market Cap: $139.54M

As of 06/28/22 04:00 PM EDT. Market closed.

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT's proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active ... read more

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT's proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of diverse therapeutic modalities across the intestinal epithelium (IE) barrier. Active transport is an efficient mechanism that uses the cell's own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing additional oral biologic product candidates in patient-friendly oral forms that are designed to either target local gastrointestinal tissue or enter systemic circulation to precisely address the relevant biology of a disease. AMT's headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
80
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$3.64
Previous Close
$3.61
Days Range
$3.23 - $3.72
52 week range
$2.67 - $47.60
Volume
237,939
Avg. Volume (30 days)
428,111
Market Cap
$139.54M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
38,654,163
Open
$3.64
Previous Close
$3.61
Days Range
$3.23 - $3.72
52 week range
$2.67 - $47.60
Volume
237,939
Avg. Volume (30 days)
428,111
Market Cap
$139.54M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
38,654,163

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR APPLIED MOLECULAR TRANSPORT INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Rich Douglas A. Chief Technical Officer Jun 02, 2022 Sale $3.04 2,602 7,917 54,475 Jun 03, 2022, 07:29 PM
Rich Douglas A. Chief Technical Officer Jun 01, 2022 Sale $2.97 2,123 6,301 57,077 Jun 03, 2022, 07:29 PM
Mrsny Randall Ph.D. Director Jun 02, 2022 Sale $3.04 392 1,193 20,039 Jun 03, 2022, 07:26 PM
Mrsny Randall Ph.D. Director Jun 01, 2022 Sale $2.97 319 947 20,431 Jun 03, 2022, 07:26 PM
Mahmood Tahir Ph.D. Chief Executive Officer Jun 02, 2022 Sale $3.04 1,693 5,151 74,925 Jun 03, 2022, 07:24 PM
Mahmood Tahir Ph.D. Chief Executive Officer Jun 01, 2022 Sale $2.97 1,382 4,102 76,618 Jun 03, 2022, 07:24 PM
Kanwar Bittoo Chief Medical Officer Jun 02, 2022 Sale $3.04 2,196 6,681 80,612 Jun 03, 2022, 07:22 PM
Kanwar Bittoo Chief Medical Officer Jun 01, 2022 Sale $2.97 1,792 5,318 82,808 Jun 03, 2022, 07:22 PM
Hants Brandon CFO Jun 01, 2022 Sale $2.97 915 2,716 34,385 Jun 03, 2022, 07:21 PM
Hants Brandon CFO Jun 02, 2022 Sale $3.04 1,122 3,414 33,263 Jun 03, 2022, 07:21 PM
Cross Shawn President & COO Jun 02, 2022 Sale $3.04 2,166 6,590 65,867 Jun 03, 2022, 07:20 PM
Cross Shawn President & COO Jun 01, 2022 Sale $2.97 1,767 5,244 67,983 Jun 03, 2022, 07:20 PM
Lamond David Director May 23, 2022 Buy $3.26 33,500 109,210 1,077,519 May 23, 2022, 06:18 PM
Lamond David Director May 20, 2022 Buy $3.08 33,000 101,640 1,044,019 May 23, 2022, 06:18 PM
EPIQ Capital Group, LLC Managing Member of 10% Owner May 13, 2022 Buy $4.17 29,763 124,124 8,337,518 May 16, 2022, 05:49 PM
EPIQ Capital Group, LLC Managing Member of 10% Owner May 12, 2022 Buy $3.88 32,380 125,634 8,307,755 May 16, 2022, 05:49 PM
VanDevender Aaron Director Mar 01, 2022 Buy $6.34 45,888 290,930 62,659 Mar 02, 2022, 05:15 PM
VanDevender Aaron Director Feb 28, 2022 Buy $6.51 4,112 26,769 16,771 Mar 02, 2022, 05:15 PM
Mahmood Tahir Ph.D. Chief Executive Officer Jan 28, 2022 Buy $7.88 3,000 23,640 3,000 Jan 31, 2022, 05:40 PM
Kanwar Bittoo Chief Medical Officer Dec 22, 2021 Option Exercise $2.38 31,500 74,970 31,500 Dec 23, 2021, 05:50 PM
Mrsny Randall Ph.D. Chief Scientific Officer Dec 09, 2021 Buy $14.99 3,500 52,464 3,500 Dec 10, 2021, 04:28 PM
EPIQ Capital Group, LLC Managing member of 10% owner Nov 17, 2021 Buy $22.38 7,135 159,684 8,275,375 Nov 18, 2021, 03:41 PM
EPIQ Capital Group, LLC Managing member of 10% owner Nov 16, 2021 Buy $22.57 4,000 90,298 8,268,240 Nov 18, 2021, 03:41 PM
Kim Helen Susan Director Aug 27, 2021 Sale $30.94 951 29,425 575,250 Aug 27, 2021, 08:45 PM
Kim Helen Susan Director Aug 26, 2021 Sale $30.16 14,063 424,074 576,509 Aug 27, 2021, 08:45 PM
Kim Helen Susan Director Aug 25, 2021 Sale $30.08 9,478 285,075 590,014 Aug 25, 2021, 09:07 PM
Kim Helen Susan Director Aug 24, 2021 Sale $30.03 508 15,255 599,495 Aug 25, 2021, 09:07 PM
Cross Shawn Chief Financial Officer Aug 19, 2021 Option Exercise $4.61 300 1,383 300 Aug 23, 2021, 07:40 PM
Cross Shawn Chief Financial Officer Aug 23, 2021 Option Exercise $4.61 9,700 44,717 9,700 Aug 23, 2021, 07:40 PM
Cross Shawn Chief Financial Officer Aug 23, 2021 Sale $30.12 9,700 292,190 0 Aug 23, 2021, 07:40 PM
Cross Shawn Chief Financial Officer Aug 19, 2021 Sale $30.01 300 9,003 0 Aug 23, 2021, 07:40 PM
Bhatt Elizabeth Chief Bus. & Strategy Officer Jul 21, 2021 Option Exercise $4.61 9,000 41,490 9,000 Jul 22, 2021, 07:59 PM
Bhatt Elizabeth Chief Bus. & Strategy Officer Jul 21, 2021 Sale $36.68 9,000 330,097 2,360 Jul 22, 2021, 07:59 PM
Kanwar Bittoo Chief Medical Officer Jul 07, 2021 Option Exercise $2.38 7,500 17,850 7,500 Jul 08, 2021, 07:49 PM
Kanwar Bittoo Chief Medical Officer Jul 07, 2021 Sale $42.09 7,500 315,693 849 Jul 08, 2021, 07:49 PM
Kim Helen Susan Director Jul 02, 2021 Sale $43.32 200,000 8,663,730 601,241 Jul 06, 2021, 07:22 PM
Bhatt Elizabeth Chief Bus. & Strategy Officer Apr 21, 2021 Option Exercise $4.61 9,000 41,490 9,000 Apr 22, 2021, 06:29 PM
Bhatt Elizabeth Chief Bus. & Strategy Officer Apr 21, 2021 Sale $40.51 9,000 364,557 8,029 Apr 22, 2021, 06:29 PM
Kanwar Bittoo Chief Medical Officer Apr 07, 2021 Option Exercise $2.38 7,500 17,850 7,500 Apr 08, 2021, 09:15 PM
Kanwar Bittoo Chief Medical Officer Apr 07, 2021 Sale $54.79 7,500 410,946 5,249 Apr 08, 2021, 09:15 PM
Kim Helen Susan Director Jul 02, 2020 Option Exercise $0.02 800,000 16,000 800,000 Jul 06, 2020, 05:41 PM
Lamond David Director Jun 09, 2020 Option Exercise $14.00 71,430 1,000,020 986,019 Jun 11, 2020, 06:38 PM
EPIQ Capital Group, LLC Managing Member of 10% owner Jun 09, 2020 Buy $14.00 2,720,000 38,080,000 8,264,240 Jun 11, 2020, 05:55 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Rich Douglas A. Chief Technical Officer 06/02/2022 7,917
Rich Douglas A. Chief Technical Officer 06/01/2022 6,301
Mrsny Randall Ph.D. Director 06/02/2022 1,193
Mrsny Randall Ph.D. Director 06/01/2022 947
Mahmood Tahir Ph.D. Chief Executive Officer 06/02/2022 5,151
Mahmood Tahir Ph.D. Chief Executive Officer 06/01/2022 4,102
Kanwar Bittoo Chief Medical Officer 06/02/2022 6,681
Kanwar Bittoo Chief Medical Officer 06/01/2022 5,318
Hants Brandon CFO 06/01/2022 2,716
Hants Brandon CFO 06/02/2022 3,414
Cross Shawn President & COO 06/02/2022 6,590
Cross Shawn President & COO 06/01/2022 5,244
Lamond David Director 05/23/2022 109,210
Lamond David Director 05/20/2022 101,640
EPIQ Capital Group, LLC Managing Member of 10% Owner 05/13/2022 124,124
EPIQ Capital Group, LLC Managing Member of 10% Owner 05/12/2022 125,634
VanDevender Aaron Director 03/01/2022 290,930
VanDevender Aaron Director 02/28/2022 26,769
Mahmood Tahir Ph.D. Chief Executive Officer 01/28/2022 23,640
Kanwar Bittoo Chief Medical Officer 12/22/2021 74,970
Mrsny Randall Ph.D. Chief Scientific Officer 12/09/2021 52,464
EPIQ Capital Group, LLC Managing member of 10% owner 11/17/2021 159,684
EPIQ Capital Group, LLC Managing member of 10% owner 11/16/2021 90,298
Kim Helen Susan Director 08/27/2021 29,425
Kim Helen Susan Director 08/26/2021 424,074
Kim Helen Susan Director 08/25/2021 285,075
Kim Helen Susan Director 08/24/2021 15,255
Cross Shawn Chief Financial Officer 08/19/2021 1,383
Cross Shawn Chief Financial Officer 08/23/2021 44,717
Cross Shawn Chief Financial Officer 08/23/2021 292,190
Cross Shawn Chief Financial Officer 08/19/2021 9,003
Bhatt Elizabeth Chief Bus. & Strategy Officer 07/21/2021 41,490
Bhatt Elizabeth Chief Bus. & Strategy Officer 07/21/2021 330,097
Kanwar Bittoo Chief Medical Officer 07/07/2021 17,850
Kanwar Bittoo Chief Medical Officer 07/07/2021 315,693
Kim Helen Susan Director 07/02/2021 8,663,730
Bhatt Elizabeth Chief Bus. & Strategy Officer 04/21/2021 41,490
Bhatt Elizabeth Chief Bus. & Strategy Officer 04/21/2021 364,557
Kanwar Bittoo Chief Medical Officer 04/07/2021 17,850
Kanwar Bittoo Chief Medical Officer 04/07/2021 410,946
Kim Helen Susan Director 07/02/2020 16,000
Lamond David Director 06/09/2020 1,000,020
EPIQ Capital Group, LLC Managing Member of 10% owner 06/09/2020 38,080,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
09/30/2021
3.67%
2Q
03/31/2022
06/30/2021
5.34%
3Q
03/31/2022
03/31/2021
9.72%
4Q

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
3.67%
2Q
06/30/2021
5.34%
3Q
03/31/2021
9.72%
4Q